Results 111 to 120 of about 12,460 (212)

Impact of Obesity on Echinocandin Effectiveness in Treating Candida Infections: A Retrospective Observational Cohort Study

Infection and Drug Resistance
Ahmad Aljohani,1,2,* Saeed Alqahtani3,* 1Pharmaceutical Care Services, King Fahd General Hospital, Ministry of Health, Jeddah, Saudi Arabia; 2Department of Pharmacy, College of Pharmacy, Nursing and Medical Sciences, Riyadh Elm University, Riyadh,
Aljohani A, Alqahtani S
doaj  

Susceptibility profile of biofilms of non-albicans Candida spp. to echinocandins

, 2012
Charles University in Prague Faculty of Pharmacy in Hradec Kralové Department of Biological and Medical Sciences Candidate: Pavla Pešková Supervisor: Ing. Lucie Křivčíková Diploma Thesis: Susceptibility profile of biofilms of non-albicans Candida spp. to
Pešková, Pavla
core  

Susceptibility profile of biofilms of non-albicans Candida spp. to echinocandins

, 2015
Charles University in Prague Faculty of Pharmacy in Hradec Kralové Department of Biological and Medical Sciences Candidate: Pavla Pešková Supervisor: Ing. Lucie Křivčíková Diploma Thesis: Susceptibility profile of biofilms of non-albicans Candida spp. to
Pešková, Pavla
core  

Global surveillance of <i>Candida albicans</i>: MIC distributions, resistance patterns, and temporal trends from the Antimicrobial Testing Leadership and Surveillance program (2015-2024). [PDF]

Antimicrob Agents Chemother
Cai G, Zhang Z.
europepmc   +1 more source

Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025. [PDF]

Emerg Infect Dis
Foo TJ, Koh MCY, Chew KL, Juay L, Wu SJ.
europepmc   +1 more source

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source

Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins

, 2017
Introduction. Invasive infections caused by Candida spp. in critically ill patients may significantly worsen their prognosis, so it is of great importance to establish an early detection and a suitable therapeutic strategy.
Grau, Santiago, Javier Candel, Francisco, Maseda, Emilio, Almirante, Benito, Guinea, Jesus, Munoz, Patricia, Garnacho-Montero, Jose, Ruiz Santana, Sergio, Moreno, Ignacio   +8 more
core  

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4. [PDF]

J Clin Microbiol
Meletiadis J, Siopi M, Meinike Jørgensen K, Escribano P, Guinea J, Arendrup MC.   +5 more
europepmc   +1 more source

FDA-Approved Antibacterials and Echinocandins

Antibiotics
Since 1955, a total of 12 peptide-based drugs with antimicrobial or antifungal properties have received approval from the Food and Drug Administration (FDA). Peptides present a promising opportunity to address serious infections that may be challenging to manage through other means. Peptides exhibit the capability to leverage various mechanisms, and in
openaire   +4 more sources

Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae. [PDF]

Genetics
Durand R, Torbey AG, Giguere M, Pageau A, Dubé AK, Lagüe P, Landry CR.   +6 more
europepmc   +1 more source